Area of research
Surgery · Endocrinology, Diabetes and Metabolism
Research interest
Research interests include Lipoproteins and Cardiovascular Health, Diabetes, Cardiovascular Risks, and Lipoproteins, Genetic Associations and Epidemiology, and Liver Disease Diagnosis and Treatment.
Target Populations for Novel Triglyceride-Lowering Therapies
Integrative common and rare variant analyses provide insights into the genetic architecture of liver cirrhosis
Women, lipids, and atherosclerotic cardiovascular disease: a call to action from the European Atherosclerosis Society
Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores
Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian Randomization
Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society
Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores
rs641738C>T near MBOAT7 is associated with liver fat, ALT and fibrosis in NAFLD: A meta-analysis
The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential
STROBE-MR: Guidelines for strengthening the reporting of Mendelian randomization studies
STROBE-MR: Guidelines for strengthening the reporting of Mendelian randomization studies
Association of<i>LPA</i>Variants With Risk of Coronary Disease and the Implications for Lipoprotein(a)-Lowering Therapies
Refining the accuracy of validated target identification through coding variant fine-mapping in type 2 diabetes
Genetic inactivation of ANGPTL4 improves glucose homeostasis and is associated with reduced risk of diabetes
Eradicating the Burden of Atherosclerotic Cardiovascular Disease by Lowering Apolipoprotein B Lipoproteins Earlier in Life
Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease
Adiposity amplifies the genetic risk of fatty liver disease conferred by multiple loci
Fifteen new risk loci for coronary artery disease highlight arterial-wall-specific mechanisms
Identification of new susceptibility loci for type 2 diabetes and shared etiological pathways with coronary heart disease
Whole-Genome Sequencing Coupled to Imputation Discovers Genetic Signals for Anthropometric Traits
Relationship between genetic variation at PPP1R3B and levels of liver glycogen and triglyceride
Refining the accuracy of validated target identification through coding variant fine-mapping in type 2 diabetes
Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease
Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment
Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease
Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society
Loss-of-Function Mutations in <i>APOC3</i> and Risk of Ischemic Vascular Disease
Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society
Genetic Associations with Valvular Calcification and Aortic Stenosis